X
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Antibody-drug conjugate
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: Apricot Capital
Deal Size: $50.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing March 01, 2021
Details:
The series A financing will help in accelerating Medilink's innovative pipeline development and to support its unique conjugate technology platform.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
